Notice: This company has been marked as potentially delisted and may not be actively trading. Nuwellis (CHFS) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsTrends CHFS vs. IRIX, BSGM, PTHL, NRXS, QTI, PXDT, STRR, CUTR, NUWE, and NDRAShould you be buying Nuwellis stock or one of its competitors? The main competitors of Nuwellis include IRIDEX (IRIX), BioSig Technologies (BSGM), Pheton Holdings Ltd Class A Ordinary Shares (PTHL), NeurAxis (NRXS), QT Imaging (QTI), Pixie Dust Technologies (PXDT), Star Equity (STRR), Cutera (CUTR), Nuwellis (NUWE), and ENDRA Life Sciences (NDRA). Nuwellis vs. IRIDEX BioSig Technologies Pheton Holdings Ltd Class A Ordinary Shares NeurAxis QT Imaging Pixie Dust Technologies Star Equity Cutera Nuwellis ENDRA Life Sciences Nuwellis (NASDAQ:CHFS) and IRIDEX (NASDAQ:IRIX) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, community ranking, media sentiment, valuation, earnings, institutional ownership, analyst recommendations, risk and dividends. Does the media favor CHFS or IRIX? In the previous week, IRIDEX had 3 more articles in the media than Nuwellis. MarketBeat recorded 3 mentions for IRIDEX and 0 mentions for Nuwellis. Nuwellis' average media sentiment score of 0.00 equaled IRIDEX'saverage media sentiment score. Company Overall Sentiment Nuwellis Neutral IRIDEX Neutral Which has preferable valuation & earnings, CHFS or IRIX? IRIDEX has higher revenue and earnings than Nuwellis. IRIDEX is trading at a lower price-to-earnings ratio than Nuwellis, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNuwellis$5.51M1.10-$18.11M-$279.280.00IRIDEX$48.43M0.56-$9.57M-$0.67-2.45 Does the MarketBeat Community prefer CHFS or IRIX? Nuwellis received 52 more outperform votes than IRIDEX when rated by MarketBeat users. Likewise, 69.53% of users gave Nuwellis an outperform vote while only 64.92% of users gave IRIDEX an outperform vote. CompanyUnderperformOutperformNuwellisOutperform Votes32469.53% Underperform Votes14230.47% IRIDEXOutperform Votes27264.92% Underperform Votes14735.08% Do institutionals and insiders hold more shares of CHFS or IRIX? 65.1% of Nuwellis shares are owned by institutional investors. Comparatively, 20.1% of IRIDEX shares are owned by institutional investors. 0.6% of Nuwellis shares are owned by company insiders. Comparatively, 7.3% of IRIDEX shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth. Is CHFS or IRIX more profitable? IRIDEX has a net margin of -22.79% compared to Nuwellis' net margin of -254.26%. Nuwellis' return on equity of -173.61% beat IRIDEX's return on equity.Company Net Margins Return on Equity Return on Assets Nuwellis-254.26% -173.61% -131.01% IRIDEX -22.79%-192.95%-33.97% Which has more risk and volatility, CHFS or IRIX? Nuwellis has a beta of 1.55, indicating that its stock price is 55% more volatile than the S&P 500. Comparatively, IRIDEX has a beta of 0.81, indicating that its stock price is 19% less volatile than the S&P 500. Do analysts recommend CHFS or IRIX? IRIDEX has a consensus target price of $2.00, suggesting a potential upside of 21.95%. Given IRIDEX's stronger consensus rating and higher probable upside, analysts clearly believe IRIDEX is more favorable than Nuwellis.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Nuwellis 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00IRIDEX 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 SummaryIRIDEX beats Nuwellis on 9 of the 16 factors compared between the two stocks. Ad Crypto 101 MediaTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… YES, I WANT THE #1 CRYPTO NOW Get Nuwellis News Delivered to You Automatically Sign up to receive the latest news and ratings for CHFS and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CHFS vs. The Competition Export to ExcelMetricNuwellisElectromedical Equipment IndustryMedical SectorNASDAQ ExchangeMarket Cap$6.04M$3.07B$5.14B$9.08BDividend YieldN/A1.75%5.09%4.23%P/E Ratio-0.0217.1690.0517.20Price / Sales1.1050.221,117.09117.04Price / CashN/A39.9143.1037.85Price / Book0.083.724.784.78Net Income-$18.11M$89.83M$120.31M$225.60M Nuwellis Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CHFSNuwellisN/A$1.00-1.0%N/A+74.2%$6.04M$5.51M-0.0266IRIXIRIDEX0.3499 of 5 stars$1.71-0.6%$2.00+17.0%-37.3%$28.45M$48.43M-2.57120Analyst ForecastNews CoverageBSGMBioSig Technologies1.2092 of 5 stars$1.60+8.8%$2.75+71.9%-67.3%$27.58M$39,000.000.0050PTHLPheton Holdings Ltd Class A Ordinary SharesN/A$4.00flatN/AN/A$26.32MN/A0.0011Positive NewsNRXSNeurAxisN/A$2.45-1.2%N/A+5.3%$17.10M$2.46M-1.3519Gap DownHigh Trading VolumeQTIQT ImagingN/A$0.46-8.4%N/AN/A$10.00M$4.00M0.00N/APXDTPixie Dust Technologies1.8569 of 5 stars$0.58+9.2%$5.21+798.4%N/A$8.62M$993.02M0.0078High Trading VolumeSTRRStar Equity1.0247 of 5 stars$2.49-5.3%N/A-57.9%$8.01M$50.38M-1.02171News CoverageGap UpHigh Trading VolumeCUTRCutera1.1044 of 5 stars$0.35-1.2%$3.00+745.5%-87.5%$7.16M$155.21M-0.05430Analyst ForecastNews CoverageGap UpNUWENuwellis1.6311 of 5 stars$1.19+0.8%$17.00+1,328.6%-95.0%$5.20M$8.86M-0.0159News CoveragePositive NewsNDRAENDRA Life Sciences1.4448 of 5 stars$4.24-0.7%$700,000.00+16,509,334.0%-100.0%$2.29MN/A-0.0120Positive NewsGap Up Related Companies and Tools Related Companies IRIX Alternatives BSGM Alternatives PTHL Alternatives NRXS Alternatives QTI Alternatives PXDT Alternatives STRR Alternatives CUTR Alternatives NUWE Alternatives NDRA Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:CHFS) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredRare "crisis signal" triggers for third time in U.S. marketA rare pattern has just repeated for the third time in U.S. history. The last two times this happened, the...Stansberry Research | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredBuffett's Oil Bet + This 22% Dividend PlayWarren Buffett has been quietly amassing a massive position in oil stocks. But while Buffett's picks (Occid...Investors Alley | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAltcoin season moves fast, and those who hesitate are left behind. The window is closing.Crypto Swap Profits | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nuwellis, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Nuwellis With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
